Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0000
0.0000
(0.00%)
At close: February 3 at 8:08:30 AM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
56,692
95,991
108,552
48,305
Total Liabilities Net Minority Interest
38,373
34,888
14,181
94,505
Total Equity Gross Minority Interest
18,319
61,103
94,371
-46,200
Total Capitalization
18,319
85,980
99,190
-42,045
Preferred Stock Equity
5,452
5,452
5,452
--
Common Stock Equity
12,867
55,651
88,919
-46,200
Capital Lease Obligations
282
278
659
992
Net Tangible Assets
18,319
61,103
94,371
-46,200
Working Capital
16,591
83,736
96,189
40,915
Invested Capital
38,141
80,528
93,738
-41,014
Tangible Book Value
12,867
55,651
88,919
-46,200
Total Debt
25,556
25,155
5,478
6,178
Net Debt
12,957
--
--
--
Share Issued
39,093.5090
38,345.1400
37,424.8630
36,994.6230
Ordinary Shares Number
39,093.5090
38,345.1400
37,424.8630
36,994.6230
12/31/2020 - 3/4/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0M4.DU Mersana Therapeutics Inc
0.4706
-5.35%
8AW0.F Ocean Biomedical, Inc.
0.0860
-3.37%
8AW0.BE Ocean Biomedical Inc
0.0945
-2.07%
8AW0.MU Ocean Biomedical Inc
0.0965
-3.50%
0M4.SG Mersana Therapeutics Inc
0.4769
-1.22%
0S90.BE Syros Pharmaceuticals Inc
0.1380
-3.50%
0S90.MU Syros Pharmaceuticals Inc
0.1440
-5.88%
AT20.F Atara Biotherapeutics, Inc.
6.55
-5.76%
8AW0.SG Ocean Biomedical Inc
0.0915
+0.55%
NV4.F Cellectar Biosciences, Inc.
0.2800
+6.87%